Sugi Predict

Sugi Predict / Compounds / SCHEMBL811867

SCHEMBL811867

SCHEMBL811867

COC(=O)C=CCCCCCCCCCCCCCCC(=O)OC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.65
▸ LMNA P02545 1/20 0.65
▸ EPHX2 P34913 1/20 0.54
▸ TSHR P16473 4/20 0.50
▸ ALOX5 P09917 2/20 0.46
▸ OXER1 Q8TDS5 1/20 0.46
▸ KEAP1 Q14145 1/20 0.43
▸ NFE2L2 Q16236 1/20 0.43
▸ HCAR2 Q8TDS4 1/20 0.43
▸ CNR2 P34972 1/20 0.43
▸ CYP3A4 P08684 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ POLA1 P09884 1/20 0.42
▸ AKT1 P31749 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ PPARG P37231 2/20 0.41
▸ PPARA Q07869 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11745557 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL3017780 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL21489709 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL23647597 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL811866 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL23073887 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL23777270 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL23647596 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL21489710 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5
SCHEMBL3017776 1.00 ALDH1A1 (0.65) ALDH1A1LMNAEPHX2TSHRALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3171869-B1 ACTIVE INGREDIENT COMPRISING A MIXTURE OF UNSATURATED DICARBOXYLIC FATTY ACIDS, COMPOSITIONS COMPRISING SAID INGREDIENT AND COSMETIC OR DERMATOLOGICAL USES SEDERMA SA (FR) 2021-10-20 — — EP disclosed
EP-3209703-B1 POLYESTERS CRODA INT PLC (GB) 2021-04-14 — — EP disclosed
CN-106794124-B9 Active ingredient containing a mixture of unsaturated dicarboxylic fatty acids, composition containing said ingredient and cosmetic or dermatological use 赛德玛公司 2020-08-21 — — CN disclosed
CN-106794124-B Active ingredient containing a mixture of unsaturated dicarboxylic fatty acids, composition containing said ingredient and cosmetic or dermatological use 赛德玛公司 2020-07-14 — — CN disclosed
US-9918916-B2 Active ingredient comprising a mixture of unsaturated dicarboxylic fatty acids, compositions comprising said ingredient and cosmetic or dermatological uses SEDERMA (FR) 2018-03-20 — — US disclosed
US-20170247505-A1 POLYESTERS CRODA INTERNATIONAL PLC (GB) 2017-08-31 — — US disclosed
EP-3209703-A1 POLYESTERS Croda International PLC (GB) 2017-08-30 — — EP disclosed
US-20170209350-A1 ACTIVE INGREDIENT COMPRISING A MIXTURE OF UNSATURATED DICARBOXYLIC FATTY ACIDS, COMPOSITIONS COMPRISING SAID INGREDIENT AND COSMETIC OR DERMATOLOGICAL USES SEDERMA (FR) 2017-07-27 — — US disclosed
EP-3087118-B1 A POLYOL BASED ON DIMER FATTY ACID RESIDUES AND THE CORRESPONDING POLYURETHANES CRODA INT PLC (GB) 2017-07-26 — — EP disclosed
US-20170198087-A1 POLYURETHANE CRODA INTERNATIONAL PLC (GB) 2017-07-13 — — US disclosed
WO-2016062999-A9 POLYESTERS CRODA INTERNATIONAL PLC (GB) 2016-06-23 — — WO disclosed
WO-2015097433-A9 A POLYOL BASED ON DIMER FATTY ACID RESIDUES AND THE CORRESPONDING POLYURETHANES CRODA INTERNATIONAL PLC (GB) 2016-06-23 — — WO disclosed
WO-2016012797-A1 ANTI-DANDRUFF COMPOSITION CRODA INTERNATIONAL PLC (GB) 2016-01-28 — — WO disclosed
WO-2016012973-A1 ACTIVE INGREDIENT COMPRISING A MIXTURE OF UNSATURATED DICARBOXYLIC FATTY ACIDS, COMPOSITIONS COMPRISING SAID INGREDIENT AND COSMETIC OR DERMATOLOGICAL USES SEDERMA (FR) 2016-01-28 — — WO disclosed
WO-2015097434-A1 POLYURETHANE CRODA INTERNATIONAL PLC (GB) 2015-07-02 — — WO disclosed
WO-2015097433-A1 A POLYOL BASED ON DIMER FATTY ACID RESIDUES AND THE CORRESPONDING POLYURETHANES CRODA INTERNATIONAL PLC (GB) 2015-07-02 — — WO disclosed
EP-2389349-A2 METHODS FOR PRODUCING DODECANEDIOIC ACID AND DERIVATIVES THEREOF Draths Corporation (US) 2011-11-30 — — EP disclosed
US-8041434-B2 Implantable medical electrical lead bodies providing improved electrode contact MEDTRONIC, INC. (US) 2011-10-18 — — US disclosed
WO-2010085712-A2 METHODS FOR PRODUCING DODECANEDIOIC ACID AND DERIVATIVES THEREOF DRATHS CORPORATION (US) 2010-07-29 — — WO disclosed
US-6159890-A Ruthenium-containing catalyst system for olefin metathesis BP AMOCO CORPORATION (US) 2000-12-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170209350-A1 ACTIVE INGREDIENT COMPRISING A MIXTURE OF UNSATURATED DICARBOXYLIC FATTY ACIDS, COMPOSITIONS COMPRISING SAID INGREDIENT AND COSMETIC OR DERMATOLOGICAL USES CUTA, ELOVL5, FASN ALDH1A1 932/4885LMNA 660/4885EPHX2 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.